» Articles » PMID: 36941492

Correlations Between Intravoxel Incoherent Motion-derived Fast Diffusion and Perfusion Fraction Parameters and VEGF- and MIB-1-positive Rates in Brain Gliomas: an Intraoperative MR-navigated, Biopsy-based Histopathologic Study

Overview
Journal Eur Radiol
Specialty Radiology
Date 2023 Mar 21
PMID 36941492
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To explore the correlations between histopathologic findings and intravoxel incoherent motion (IVIM)-derived perfusion and diffusion parameters in brain gliomas.

Methods: Thirty-two biopsy samples from twenty-one patients with newly diagnosed gliomas from a previous prospective cohort study were retrospectively analyzed. All patients underwent diffusion-weighted MRI with 22 b values (0-5000 s/mm), followed by intraoperative MR-guided biopsy surgery and surgical resection. All 32 biopsy samples underwent immunohistochemical staining followed by quantitative analysis of cell density (cellularity), percent of MIB-1 (Ki67)-positive expression (pMIB-1), number of CD34-stained vessels (CD34-MVD), and percent of VEGF-positive expressing cells (pVEGF) using a multispectral phenotyping microscope. Based on the co-registered localized biopsy, correlation analysis was performed between the IVIM-derived biexponential model-based parameters (Dfast1500 and Dfast5000, Dslow1500 and Dslow5000, PF1500 and PF5000) and the above four pathological biomarkers and glioma grades.

Results: Significant positive correlations were revealed between Dfast5000 and pVEGF (rho (r) = 0.466, p = 0.007), and Dfast1500 and pVEGF (r = 0.371, p = 0.037). A significant negative correlation was revealed between PF5000 with pMIB-1 (r =  - 0.456, p = 0.01). Moderate to good positive correlations were shown between Dfast5000 and glioma grades (r = 0.509, p = 0.003) and Dfast1500 and glioma grades (r = 0.476, p = 0.006).

Conclusions: IVIM-DWI-derived Dfast and PF correlate, respectively, with intratumor pVEGF and pMIB-1. When using the wide-high b value scheme, IVIM-derived Dfast and PF tend to demonstrate better efficacy in evaluating malignancy-related characteristics such as angiogenesis and cellular proliferation in gliomas.

Key Points: • Intravoxel incoherent motion-diffusion-weighted imaging (IVIM-DWI)-derived fast diffusion (Dfast) and perfusion fraction (PF) can quantitatively reflect intratumor pVEGF and pMIB-1. • IVIM-DWI-derived Dfast and PF tend to demonstrate better efficacy in evaluating glioma malignancy when an optimized scheme is used. • IVIM-DWI-derived Dfast5000 and PF5000 are promising non-invasive parameters correlating with pVEGF and pMIB-1 in gliomas.

Citing Articles

Research Progress on Glioma Microenvironment and Invasiveness Utilizing Advanced Multi-Parametric Quantitative MRI.

Song D, Fan G, Chang M Cancers (Basel). 2025; 17(1.

PMID: 39796702 PMC: 11719598. DOI: 10.3390/cancers17010074.


Cardiac intravoxel incoherent motion diffusion-weighted imaging to assess myocardial microcirculation dysfunction in hypertension.

Zhao L, Wang H, Qiu D, Tian L, Wang T, Yang Y Quant Imaging Med Surg. 2024; 14(8):5346-5357.

PMID: 39143998 PMC: 11320536. DOI: 10.21037/qims-24-108.


Image Omics Nomogram Based on Incoherent Motion Diffusion-Weighted Imaging in Voxels Predicts ATRX Gene Mutation Status of Brain Glioma Patients.

Lin X, Wang C, Zheng J, Liu M, Li M, Xu H J Imaging Inform Med. 2024; 37(4):1336-1345.

PMID: 38378963 PMC: 11300756. DOI: 10.1007/s10278-024-00984-4.


A Progressively Disassembled DNA Repair Inhibitors Nanosystem for the Treatment of BRCA Wild-Type Triple-Negative Breast Cancer.

Fang W, Wang J, Ma X, Shao N, Ye K, Zhang D Int J Nanomedicine. 2023; 18:6001-6019.

PMID: 37901361 PMC: 10612513. DOI: 10.2147/IJN.S426639.


Multi-b-value diffusion stretched-exponential model parameters correlate with MIB-1 and CD34 expression in Glioma patients, an intraoperative MR-navigated, biopsy-based histopathologic study.

Wang J, Zhang H, Dang X, Rui W, Cheng H, Wang J Front Oncol. 2023; 13:1104610.

PMID: 37182187 PMC: 10171458. DOI: 10.3389/fonc.2023.1104610.

References
1.
LaPointe S, Perry A, Butowski N . Primary brain tumours in adults. Lancet. 2018; 392(10145):432-446. DOI: 10.1016/S0140-6736(18)30990-5. View

2.
Ostrom Q, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C . CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014. Neuro Oncol. 2017; 19(suppl_5):v1-v88. PMC: 5693142. DOI: 10.1093/neuonc/nox158. View

3.
Louis D, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee W . The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016; 131(6):803-20. DOI: 10.1007/s00401-016-1545-1. View

4.
Nitta M, Muragaki Y, Maruyama T, Ikuta S, Komori T, Maebayashi K . Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection. Neurosurg Focus. 2015; 38(1):E7. DOI: 10.3171/2014.10.FOCUS14651. View

5.
Ganau L, Paris M, Ligarotti G, Ganau M . Management of Gliomas: Overview of the Latest Technological Advancements and Related Behavioral Drawbacks. Behav Neurol. 2015; 2015:862634. PMC: 4546744. DOI: 10.1155/2015/862634. View